Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 951-1000 of 6028 result(s).
CYDY CytoDyn Inc
12/16/2023 2:43:10 AM
I think that was the glioblastoma p (2)
CYDY CytoDyn Inc
12/15/2023 7:42:34 AM
Ignore the post on Stuttgart. That (3)
CYDY CytoDyn Inc
12/15/2023 6:13:52 AM
Thinking about it, where I've read (3)
CYDY CytoDyn Inc
12/15/2023 1:21:29 AM
A reply I made in a PM to someone. (8)
CYDY CytoDyn Inc
12/15/2023 12:41:33 AM
I just took a look at the 8-K. A sa (3)
CYDY CytoDyn Inc
12/15/2023 12:28:27 AM
clarity please on "second hold" - d (13)
CYDY CytoDyn Inc
12/15/2023 12:13:00 AM
It will be very interesting to see (18)
CYDY CytoDyn Inc
12/14/2023 4:47:46 PM
I added 1% more shares to my total (13)
CYDY CytoDyn Inc
12/13/2023 6:02:40 PM
Unfortunately the FDA would not app (18)
CYDY CytoDyn Inc
12/13/2023 6:14:54 AM
Just, when you say, "it causes HIV (14)
CYDY CytoDyn Inc
12/13/2023 2:24:53 AM
I totally concur. Can someone havin (7)
CYDY CytoDyn Inc
12/13/2023 2:22:40 AM
In HIV, the chronic inflammation wh (22)
CYDY CytoDyn Inc
12/11/2023 7:34:59 PM
Thanks for the link. The Many Faces (15)
CYDY CytoDyn Inc
12/11/2023 7:16:38 PM
I didn't see any reference to possi (15)
CYDY CytoDyn Inc
12/11/2023 10:03:12 AM
When it comes to CCR5 they seem as (3)
CYDY CytoDyn Inc
12/11/2023 9:49:58 AM
Grip it, the problem with HIV vacci (19)
CYDY CytoDyn Inc
12/10/2023 1:18:49 AM
A tip of the hat to MGK for transcr (18)
CYDY CytoDyn Inc
12/10/2023 1:03:10 AM
OHM, what do you think about the pr (14)
CYDY CytoDyn Inc
12/10/2023 12:57:47 AM
Ohm, I would love to hear your thou (20)
CYDY CytoDyn Inc
12/09/2023 6:25:26 AM
Interleukin-1 (IL-1) and interleuki (10)
CYDY CytoDyn Inc
12/09/2023 6:19:05 AM
Longing for the day when other peop (18)
CYDY CytoDyn Inc
12/08/2023 7:27:55 AM
My last post had me thinking about (28)
CYDY CytoDyn Inc
12/08/2023 6:58:04 AM
It's unreasonable. Now that leronli (8)
CYDY CytoDyn Inc
12/06/2023 5:41:33 PM
Used PRO 140 as assay. With leronli (17)
CYDY CytoDyn Inc
12/02/2023 12:06:37 AM
It's fairly rare for a judge to ord (9)
CYDY CytoDyn Inc
11/29/2023 6:32:45 PM
When I saw in the 10-K that we had (7)
CYDY CytoDyn Inc
11/29/2023 6:27:19 PM
Bivi's drug NE3107 binds ERK1 and 2 (5)
CYDY CytoDyn Inc
11/28/2023 2:46:09 PM
That said, once we get past the hol (9)
CYDY CytoDyn Inc
11/28/2023 2:38:42 PM
According to the protocol at clinic (6)
CYDY CytoDyn Inc
11/27/2023 11:07:14 PM
So does that mean Cytodyn has to cr (20)
CYDY CytoDyn Inc
11/27/2023 9:46:26 PM
The response times are guidelines t (2)
CYDY CytoDyn Inc
11/26/2023 12:06:44 AM
Wes Christian wants companies to hi (13)
CYDY CytoDyn Inc
11/25/2023 2:43:35 AM
This is a stretch I know, but I bel (9)
CYDY CytoDyn Inc
11/24/2023 2:49:07 PM
In cytokine induced bone loss, lero (10)
CYDY CytoDyn Inc
11/24/2023 2:37:44 PM
The particular calcium (CA2+) that (11)
CYDY CytoDyn Inc
11/24/2023 1:09:57 AM
Something that stood out to me watc (22)
CYDY CytoDyn Inc
11/24/2023 12:38:50 AM
I always thought that Cyrus was WRO (19)
CYDY CytoDyn Inc
11/23/2023 1:29:20 AM
But the third party auditors were n (11)
CYDY CytoDyn Inc
11/22/2023 7:49:33 PM
I don't think Cyrus would give up u (28)
CYDY CytoDyn Inc
11/22/2023 7:30:44 PM
That discussion may be interesting (12)
CYDY CytoDyn Inc
11/22/2023 12:52:08 AM
Does anyone know how inclined Dr La (14)
CYDY CytoDyn Inc
11/21/2023 2:34:18 PM
I woke up to a bit of confusion. Wh (27)
CYDY CytoDyn Inc
11/20/2023 12:19:11 AM
That is more of an FDA regulatory q (9)
CYDY CytoDyn Inc
11/19/2023 3:38:06 PM
It's possible that study was three- (9)
CYDY CytoDyn Inc
11/18/2023 3:42:58 AM
I almost forgot about Resmetirom th (8)
CYDY CytoDyn Inc
11/18/2023 12:18:15 AM
going to also fantasize that leronl (22)
CYDY CytoDyn Inc
11/17/2023 2:34:08 PM
There may very well be synergy betw (8)
CYDY CytoDyn Inc
11/16/2023 10:35:52 PM
It would depend on the agreement. W (4)
CYDY CytoDyn Inc
11/16/2023 9:20:15 PM
Cytodyn delivered the initial items (13)
CYDY CytoDyn Inc
11/16/2023 7:32:23 PM
paraphrase since the post was delet (4)
Go to page:
  • << First
  • < Previous
  • 19
  • 20
  • Next >

Recent Articles

  • Tevogen's CEO Dr. Ryan Saadi Donates Shares to local Charity
  • Shareholder Investigations of Merger Activities Involving Four Companies
  • Sarepta Therapeutics Faces Class Action Over Drug Safety Claims
  • Understanding Capricor Therapeutics: Investor Insights & Updates
  • Discover the Growth Potential of Cloudflare Investments
  • Alto Neuroscience Investors Encouraged to Recover Losses Promptly
  • Understanding Amazon.com Inc.'s Price Earnings Ratio Trends
  • Agora, Inc. Sees Steady Growth in Q2 Results Highlighting AI Tech
  • SelectQuote Investors Can Join Important Securities Class Action
  • Join Investors to Empower XPLR Infrastructure Legal Action
  • Marc Goldstein Honored on Silicon Valley Arbitration Tech List
  • Understanding Simulations Plus, Inc. Class Action Rights
  • Understanding Inflation Dynamics Amid Recent Economic Trends
  • Trump's Economic Strategy: Understanding Miran's Impact
  • Microsoft Stock Trends Towards Bullish Momentum in September
  • LYNO AI's Token Presale Sees Surge in Investor Enthusiasm
  • Agora, Inc. Achieves Profitability in Second Quarter 2025
  • Cohen Circle Acquisition Corp. II Initiates Trading for Shares and Warrants
  • Amaero Ltd: Record Revenue and Strategic Advancements Ahead
  • Eagle Pharmaceuticals Sets Date for Its Annual Meeting in 2025
  • Exciting New Leadership at United Fire Group's Board
  • Unitil Corporation Secures $74.75 Million from Stock Offering
  • Graphjet Partners with Universiti Kebangsaan Malaysia for Innovation
  • Heritage Commerce Corp Welcomes New Board Member Christopher Abate
  • Dr. Ryan Saadi's Generous Contribution to Local Police Efforts
  • Investigation of Mergers: Key Insights for Shareholders
  • Unlocking HomeSearch AI: A New Era in Real Estate Technology
  • Understanding the Financial Growth of Kratos Defense Stock
  • Understanding the Growth of Ingersoll Rand Investment Over Time
  • Intellistake Technologies Announces New Private Placement Details
  • Investors Can Join the Class Action Against Flywire Corp.
  • Mullen & Mullen Injury Law Firm Celebrates 2025 Obelisk Honor
  • Enbridge Confirms Results for Series 15 Shares Conversion
  • Waldencast's Strategic Moves Set to Enhance Market Position
  • Hydreight Expands Options with $10 Million Debenture Offering
  • Navigating Mergers: Legal Insights on RGLD, SNV, ZIMV, and MESA
  • Class Action Inquiry: Understanding Mergers and Shareholder Rights
  • Exploring the Dynamic Growth of the TSLP Inhibitors Market
  • Legal Representation for Property Owners Against SMART Authority
  • Transforming Real Estate with HomeSearch AI by Inside Real Estate
  • Tevogen CEO's Generous Donation Empowers Brain Injury Recovery
  • ISC Partners with Ontario for Advanced Property Info System
  • Tevogen Bio: Empowering Brain Injury Recovery Through Philanthropy
  • Investigation of Mergers: VBTX, CFSB, PVBC, and DRRX Updates
  • Understanding ONEOK's Stock Growth: A Five-Year Journey
  • Investors of Nutex Health Inc. Share Losses Amid Concerns
  • Exciting Launch of Nuestra Cancha by reVolver Podcasts
  • Rocket Companies Poised for Growth Amid Housing Market Changes
  • ISC Partners with Ontario for Advanced Digital Property Solutions
  • Critical One Energy Expands Private Placement Amid Demand
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site